The systematic study conducted by Sun et al details that PS19 mice exhibit stronger phenotypes regarding weight loss, survival rate, composite phenotype assessment, tau phosphorylation, and neuroinflammation, representing a more sensitive platform for investigating tauopathy.48 The gene discussed is MAPT; the disease is tauopathy.